Brief: IPSEN: Arbitration Tribunal Upholds Ipsen's Termination Of Research And Development Agreement With Galderma
Jan 21 (Reuters) - Ipsen SA IPN.PA: IPSEN: ARBITRATION TRIBUNAL UPHOLDS IPSEN’S TERMINATION OF RESEARCH AND DEVELOPMENT AGREEMENT WITH GALDERMA IPSEN SAYS ICC DISMISSES GALDERMA'S CLAIM IN ARBITRATION IPSEN CEO: WE CONTINUE TO ASSESS ALL OPTIONS TO MAXIMIZE VALUE OF IPN10200 Source text: nGNX76KcgH Further company coverage: IPN.PA (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))
Recent news on Ipsen SA
See all newsHealth Rounds: New blood test matches gold standard for liver disease diagnosis
Brief: Ipsen Late-Breaking Data Raises Ambitions In PBC
Brief: Charles River Laboratories International Virtual Control Group To Be Used In Glp Study For Ipsen
Pharming shares rise after preliminary Q3 revenue beat
France's Ipsen Q3 sales rise 28% driven by core portfolio